Artificial Chromosome Vector for Stable Protein Expression

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for recombinant protein production in mammalian cell systems face challenges such as lack of reproducibility, positional effects of chromatin integration, and silencing of protein expression over time, making the selection of suitable clones tedious and time-consuming.

Innovation Solution

A eukaryotic production host cell line is developed using at least 5 copies of a bacterial artificial chromosome (BAC) randomly integrated into the host cell chromosome, which includes promoters like CMV, Caggs, thymidine kinase, ubiquitin C, or EF2, and is integrated into open chromatin loci such as Rosa26, beta-actin, GAPDH, or ribosomal protein loci, providing a stable and high-yield protein expression system.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If random genomic integration of expression vectors is used, then the method is simple and straightforward, but expression is silenced over time due to chromatin positional effects

Engineering Contradiction:
Improvesimplicity of methodVSAvoidstability of expression
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent uses chromatin insulator elements (such as cHS4) as intermediary components that flank the expression cassette to block the propagation of silencing signals from surrounding chromatin. These insulator elements act as protective barriers that maintain open chromatin configuration and prevent heterochromatin spreading, thereby preserving long-term expression stability without complicating the overall vector design

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent modifies the chromatin structure parameters by incorporating specific regulatory elements that maintain an open, transcriptionally active chromatin state. By changing the chromatin configuration from closed/silenced to open/active through the use of insulator elements and selectable marker positioning, the system achieves stable long-term expression while maintaining methodological simplicity

Inventive Principle:
Principle #35Parameter changes

2Reliability

If anti-repressor elements or specific chromatin loci integration is used, then positional effects are overcome, but the procedure becomes tedious and time-consuming

Engineering Contradiction:
Improveexpression stabilityVSAvoidtime for clone selection
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent employs a selectable marker gene (such as neomycin resistance) integrated within the expression cassette that enables automatic selection of successfully transfected cells. This self-service mechanism allows cells that have incorporated the expression vector to autonomously identify themselves through resistance to selective agents, eliminating the need for tedious manual screening and significantly reducing clone selection time while maintaining expression stability

Inventive Principle:
Principle #25Self-service

3Productivity

If multiple copies of BAC are integrated, then protein yield increases by factor of 10, but the complexity of integration increases

Engineering Contradiction:
Improveprotein yieldVSAvoidintegration complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent divides the expression system into modular segments: the BAC vector backbone, the expression cassette with insulator elements, and the selectable marker. This segmentation allows multiple BAC copies to be independently integrated into the genome without interfering with each other, enabling high protein yield through multi-copy integration while managing complexity through standardized modular components that can be assembled and introduced systematically

Inventive Principle:
Principle #1Segmentation

Data Source

PatentEP3372687B1Artificial chromosome vector
Publication Date: 2022.01.12 BAUER GES MBH
  • EP3372687B1 patent drawingFigure 1A
  • EP3372687B1 patent drawingFigure 1B
  • EP3372687B1 patent drawingFigure 1C

AI summary

A method of producing a protein in a eukaryotic cell line, comprising the steps of a) providing a backbone of an artificial chromosome, b) recombining the nucleic acid encoding said protein into said backbone to generate an expression vector, c) introducing said expression vector into a eukaryotic host cell line to obtain a eukaryotic expression cell line, d) cultivating said expression cell line to produce said protein, and e) isolating said protein.